The decisions that determine Phase 2 timing are made, or missed, in the first two quarters after the IND opens.
White Paper
IND Ready Is Not Phase 2 Ready
Related Resources
All Resources
post
Understanding the Phases of FDA Approval for Drug Development
Read More
post
The Next Generation of Regulatory Submissions: Exploring the Benefits of eCTD 4.0
Read More
post
Understanding the Nuances of a Clinical Study Protocol
Read More
post
Why Regulatory Affairs is Important in Drug Approval
Read More
Let's move from science to success.
Let’s Talk